Vildagliptin Compared to Gliclazide as Dual Therapy With Metformin in Muslim Patients With Type 2 Diabetes Fasting During Ramadan
Clinical trial NCT01758380 · COMPLETED
Trial details
- NCT number
- NCT01758380
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2013-09-01
- Enrollment
- 557
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.